Mission and values
Since our creation, we have always aimed at providing the biopharmaceutical industry with innovative solutions in order to take part in the development of new therapies. Individuals are at the heart of our considerations and our projects; our customers, our providers, our partners and our own team are all given a particular attention. Trust and benevolence are Clean Cells’ core values and we endeavor to apply them in all circumstances. After 18 years working for the enhanced safety of biologics and building our team’s expertise, Clean Cells is now using the momentum to establish itself as a CDMO for innovative therapies.
Our goal remains the same: do our part in patients’ well-being.
Olivier Boisteau, President and CEO at Clean Cells
Scientific journalSee all files
In the news
Characterization of lentiviral vectors and RCL “pool” assay
Clean Cells has partnered with customers on numerous gene therapy testing projects, including dozens of lentiviral vectors and CAR-T products. The company has now developed and validated a novel method to streamline replication competent lentivirus testing under GMPs, known as the RCL “pool” assay.
NewsSee all news
Clean Biologics was born in 2018 from a fruitful alliance between Clean Cells and Archimed. Through this partnership, the group soon acquired and integrated CDMO Naobios to extend the service offer and to promote our future-oriented thinking. The expertise, transparency, progress and a human-centred view are at the core of our identity. Day after day, we use our knowledge and our skills to deliver high-quality services in innovative projects with an unwavering dynamism and commitment.
customers around the world
analysis per year